FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/089981 [Registered on: 02/07/2025] Trial Registered Prospectively
Last Modified On: 02/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Controlled Trial to Compare the Efficacy of Jeemutak Varti and Corect Suppository in The Reduction of Size of Grade I And Grade II piles w.s.r. to Abhyantar Arsha 
Scientific Title of Study   A Randomized Controlled Trial to Compare the Effectiveness of Jeemutak Varti and Corect Suppository in The Reduction of Size of Grade I And Grade II Haemorrhoids w.s.r. to Abhyantar Arsha 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR LOCHAN SINGH KHANDAGALE 
Designation  Ph.D SCHOLAR , Associate Professor 
Affiliation  SHRI AYURVED MAHAVIDAYALAYA AND PAKWSA SAMNVAYA RUGNALAYA  
Address  Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Nagpur
MAHARASHTRA
440009
India 
Phone  9425664699  
Fax    
Email  drlochan999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR JYOTI NILKANTHA SHINDE 
Designation  HOD AND PROFESSOR 
Affiliation  SHRI AYURVED MAHAVIDAYALAYA AND PAKWSA SAMNVAYA RUGNALAYA  
Address  Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Nagpur
MAHARASHTRA
440009
India 
Phone  9975830051  
Fax    
Email  drjyoti.dalal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR LOCHAN SINGH KHANDAGALE 
Designation  Ph.D SCHOLAR , Associate Professor 
Affiliation  DHANWANTRI MARG HANUMAN NAGAR NAGPUR MAHARASTRA 
Address  Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Nagpur
MAHARASHTRA
440009
India 
Phone  9425664699  
Fax    
Email  drlochan999@gmail.com  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  shri ayurved mahavidayala pakwasa and samanvaya rugnalaya nagpur 
Address  Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
dr lochan singh khandagale  shri ayurved mahavidayala pakwasa and samanvaya rugnalaya nagpurDhanwantri Marg Hanuman Nagar nagpur Maharastra 440009 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
lochan singh khandagale  shri ayurved mahavidayala pakwasa and samanvaya rugnalaya nagpur  Shalya Tantra Opd No. 07 Pakwasa Samnvaya Rugnalaya Shri Ayurved Mahavidayalya Dhanwantri Marg Hanuman Nagar Nagpur Maharastra
Nagpur
MAHARASHTRA 
9425664699

drlochan999@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethical commitiee report  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K928||Other specified diseases of the digestive system. Ayurveda Condition: ARSAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-gudavarti गुदवित Pradhan Karma(Procedure Reference: 81, Procedure details: 1. Under all aseptic precautions, under appropriate anesthesia, the patient will laid down in lithotomy position. 2. Painting of perianal area will be done. 3. Then, as lit proctoscope lubricated with LOX jelly will be introduced in the anal canal. 5. Pile mass will be identified and cleaned with dry gauze. 6. Jeemutak varti will be inserted into anal canal with lox 2% jelly)
(1) Medicine Name: jeemutak guda varti, Reference: 81, Route: Rectal, Dosage Form: Varti/ Suppository, Dose: 1(mg), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1) Diagnosed patients of I and II grade Haemorrhoids in the age group of 20-60 yrs.
2) Selection will be irrespective of gender, religion, education and socio-economic
status of the patients. 
 
ExclusionCriteria 
Details  1) Patients with grade III and IV degree Haemorrhoids.
2) Patients suffering from different pathologies of anal canal and rectum like
carcinoma rectum and anal canal, ulcerative colitis, proctitis etc.
3) Patients with uncontrolled diabetes mellitus, immune-compromised, liver
cirrhosis patients.
4) Known patients of portal hypertension will be excluded 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
it is expected to end of the study we should able to Know the effcacy of ayurvedic treatment protocol in the managment of second degree hemorroids  it is expected to end of the study we should able to Know the effcacy of allopathic suppository treatment protocol in the managment of second degree hemorroids 
 
Secondary Outcome  
Outcome  TimePoints 
it is expected to end of the study we should able to Know the effcacy of allopathic suppository treatment protocol in the managment of second degree hemorroids  it is expected to it take 1 year & 8 months  
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   25/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  31/07/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study aims to compare the clinical efficacy of Jeemutak Varti, a classical Ayurvedic formulation, and Corect Suppository, a modern pharmaceutical formulation, in managing Grade I and Grade II internal hemorrhoids (Abhyantar Arsha).A randomized controlled trial was conducted on 64 patients, equally divided into two groups. Group A received Jeemutak Varti and Group B received Corect Suppository per rectum for 14 days. Parameters such as pile mass size, pain, bleeding per rectum, and discomfort were assessed before, during, and after treatment. The study seeks to provide a comparative understanding of traditional and modern therapeutic approaches in Arsha Chikitsa  
Close